These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7900283)

  • 21. The N-terminal env-derived amino acids of v-rel are required for full transforming activity.
    Garson K; Percival H; Kang CY
    Virology; 1990 Jul; 177(1):106-15. PubMed ID: 2162102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncogene and its potential role in carcinogenesis.
    Wong-Staal F
    Arch Toxicol Suppl; 1985; 8():61-72. PubMed ID: 3006636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein phosphorylation and cell transformation.
    Hanafusa H
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):1-9. PubMed ID: 1718667
    [No Abstract]   [Full Text] [Related]  

  • 24. The human CBL oncogene.
    Langdon WY; Blake TJ
    Curr Top Microbiol Immunol; 1990; 166():159-64. PubMed ID: 2073794
    [No Abstract]   [Full Text] [Related]  

  • 25. Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells.
    Li R; Zhou RP; Duesberg P
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7522-7. PubMed ID: 8755507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of transformation by the v-rel oncogene.
    Hannink M; Temin HM
    Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.
    Blake TJ; Shapiro M; Morse HC; Langdon WY
    Oncogene; 1991 Apr; 6(4):653-7. PubMed ID: 2030914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
    Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
    Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The localization of the products of the c-cbl and v-cbl oncogenes during mitosis and transformation.
    Langdon WY; Heath KG; Blake TJ
    Curr Top Microbiol Immunol; 1992; 182():467-74. PubMed ID: 1490387
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.
    Staal SP
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5034-7. PubMed ID: 3037531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. v-erb A, nuclear hormone receptors, and oncogenesis.
    Privalsky ML
    Biochim Biophys Acta; 1992 Sep; 1114(1):51-62. PubMed ID: 1356442
    [No Abstract]   [Full Text] [Related]  

  • 32. An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis.
    Troppmair J; Potter M; Wax JS; Rapp UR
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9941-5. PubMed ID: 2690079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrovirus, oncogenes and malignant transformation].
    Fernández-Cruz E
    Rev Clin Esp; 1986 Nov; 179(8):389-91. PubMed ID: 3031749
    [No Abstract]   [Full Text] [Related]  

  • 34. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
    Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
    Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotechnology, viral oncogenesis and jaagsiekte.
    Verwoerd DW
    Onderstepoort J Vet Res; 1985 Sep; 52(3):145-8. PubMed ID: 3003648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral myc genes and their cellular homologs.
    Papas TS; Lautenberger JA; Kan NC; Watson DK; Van Beneden R; Psallidopoulos M; Fisher RJ; Fujiwara S; Samuel K; Flordellis C
    Gene Amplif Anal; 1986; 4():109-42. PubMed ID: 2851528
    [No Abstract]   [Full Text] [Related]  

  • 37. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structures and activities of activated abl oncogenes.
    Risser R; Holland GD
    Curr Top Microbiol Immunol; 1989; 147():129-53. PubMed ID: 2695292
    [No Abstract]   [Full Text] [Related]  

  • 39. Transformation of a mammary epithelial cell line by the v-raf and v-mos oncogenes.
    Scully JL; Edwards PA
    Int J Cancer; 1991 Apr; 48(1):128-35. PubMed ID: 1826898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
    J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.